Dr. Reddy's Laboratories Limited Share Price NSE India S.E.
Equities
DRREDDY
INE089A01023
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,252 INR | +0.54% | +5.20% | +7.83% |
Sales 2024 * | 279B 3.34B 268B | Sales 2025 * | 299B 3.58B 287B | Capitalization | 1,041B 12.49B 1,000B |
---|---|---|---|---|---|
Net income 2024 * | 54.64B 655M 52.48B | Net income 2025 * | 56.74B 681M 54.49B | EV / Sales 2024 * | 3.5 x |
Net cash position 2024 * | 66.43B 797M 63.8B | Net cash position 2025 * | 105B 1.26B 101B | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
19
x | P/E ratio 2025 * |
18.3
x | Employees | 25,863 |
Yield 2024 * |
0.65% | Yield 2025 * |
0.7% | Free-Float | 91.52% |
Latest transcript on Dr. Reddy's Laboratories Limited
1 day | +0.54% | ||
1 week | +5.20% | ||
Current month | +1.53% | ||
1 month | +3.44% | ||
3 months | +6.77% | ||
6 months | +15.84% | ||
Current year | +7.83% |
Managers | Title | Age | Since |
---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 01/04/18 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 01/11/20 |
Chairman | 56 | 17/01/93 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 07/04/86 |
Chairman | 56 | 17/01/93 | |
Kalpana Morparia
BRD | Director/Board Member | 73 | 04/06/07 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6,252 | +0.54% | 412,618 |
25/04/24 | 6,219 | +4.50% | 926,985 |
24/04/24 | 5,951 | -0.02% | 266,987 |
23/04/24 | 5,952 | -1.06% | 298,835 |
22/04/24 | 6,016 | +1.23% | 333,457 |
Delayed Quote NSE India S.E., April 26, 2024 at 12:43 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- DRREDDY Stock
- DRREDDY Stock